{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [],
  "article_type": null,
  "arxiv": null,
  "author_total": 26,
  "authors": [
    {
      "name": "Georgina Long"
    },
    {
      "name": "Charlie Garnett-Benson"
    },
    {
      "name": "Sonia Dolfi"
    },
    {
      "name": "Paolo Ascierto"
    },
    {
      "name": "Jun Guo"
    },
    {
      "name": "Ahmad Tarhini"
    },
    {
      "name": "Sunandana Chandra"
    },
    {
      "name": "Eva Muñoz-Couselo"
    },
    {
      "name": "Michele del Vecchio"
    },
    {
      "name": "Andreia Cristina de Melo"
    },
    {
      "name": "Margaret Callahan"
    },
    {
      "name": "Helen Gogas"
    },
    {
      "name": "Reinhard Dummer"
    },
    {
      "name": "Dirk Schadendorf"
    },
    {
      "name": "Peter Koelblinger"
    },
    {
      "name": "Gaelle Quereux"
    },
    {
      "name": "Ioannis Thomas"
    },
    {
      "name": "Jia Xin Yu"
    },
    {
      "name": "Andrew Fisher"
    },
    {
      "name": "Bonnie Wang"
    },
    {
      "name": "Patrick Djidel"
    },
    {
      "name": "Armand Chouzy"
    },
    {
      "name": "Mark Semaan"
    },
    {
      "name": "Bohang Chen"
    },
    {
      "name": "Alicia Cheong"
    },
    {
      "name": "Hussein Tawbi"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/cyketf80dfp70.bib",
  "cited_by": 0,
  "doi": "10.1080/14796694.2026.2721180",
  "fulltext_url": null,
  "id": "cyketf80dfp70",
  "issns": [
    "1479-6694",
    "1744-8301"
  ],
  "landing_url": "https://inserm.hal.science/inserm-05761043v1",
  "language": "en",
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "hal",
      "0.sdv"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7214023003",
  "pdf_url": "https://inserm.hal.science/inserm-05761043/document",
  "pmcid": null,
  "pmid": "42770835",
  "published": "2026-09-22",
  "publisher": "Future Medicine",
  "ris": "https://research.draconitic.com/paper/cyketf80dfp70.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:39Z",
      "native_id": "inserm-05761043",
      "source": "hal",
      "url": "https://inserm.hal.science/inserm-05761043v1"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery",
  "title_text": "Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:17:39Z",
  "url": "https://research.draconitic.com/paper/cyketf80dfp70",
  "venue": "Future Oncology",
  "versions": []
}